1. Roles for the long non-coding RNA Pax6os1 / PAX6-AS1 in pancreatic beta cell function.
- Author
-
Lopez-Noriega L, Callingham R, Martinez-Sánchez A, Nawaz S, Pizza G, Haberman N, Cvetesic N, Nguyen-Tu MS, Lenhard B, Marchetti P, Piemonti L, de Koning E, Shapiro AMJ, Johnson PR, Leclerc I, Hastoy B, Gauthier BR, Pullen TJ, and Rutter GA
- Abstract
Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of beta cell function. Here, we show that an lncRNA-transcribed antisense to Pax6, annotated as Pax6os1/PAX6-AS1, was upregulated by high glucose concentrations in human as well as murine beta cell lines and islets. Elevated expression was also observed in islets from mice on a high-fat diet and patients with type 2 diabetes. Silencing Pax6os1 / PAX6-AS1 in MIN6 or EndoC-βH1 cells increased several beta cell signature genes' expression. Pax6os1/PAX6-AS1 was shown to bind to EIF3D, indicating a role in translation of specific mRNAs, as well as histones H3 and H4, suggesting a role in histone modifications. Important interspecies differences were found, with a stronger phenotype in humans. Only female Pax6os1 null mice fed a high-fat diet showed slightly enhanced glucose clearance. In contrast, silencing PAX6-AS1 in human islets enhanced glucose-stimulated insulin secretion and increased calcium dynamics, whereas overexpression of the lncRNA resulted in the opposite phenotype., Competing Interests: G.A.R. has received grant funding and consultancy fees from Sun Pharmaceuticals Inc. The remaining authors declare no conflict of interest., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF